1.Ying Su^*, Ziteng Li^*, Qin Li^*, Xinyi Guo, Hena Zhang, Yan Li , Zhiqiang Meng^#, Shenglin Huang^#, Zhixiang Hu^#. Oncofetal TRIM71 drives liver cancer carcinogenesis through remodeling CEBPA-mediated serine/glycine metabolism. Theranostics. 2024.14(13):4948-4966. doi: 10.7150/thno.99633.

2. Qin Li^*, Ziteng Li^*, Bing Chen, Jingjing Zhao, Hongwu Yu, Jia Hu, Hongyan Lai, Hena Zhang, Yan Li, Zhiqiang Meng, Zhixiang Hu^#, Shenglin Huang^#. RNA splicing junction landscape reveals abundant tumor-specific transcripts in human cancer.Cell Reports. 2024. 43(11):114893. doi: 10.1016/j.celrep.2024.114893.

3. Zhixiang Hu^*, Xinyi Guo, Ziteng Li, Zhiqiang Meng^#, Shenglin Huang^#. The neoantigens derived from transposable elements - A hidden treasure for cancer immunotherapy. Biochim Biophys Acta Rev Cancer. 2024. 1879(5):189126. doi: 10.1016/j.bbcan.2024.189126.

4. Xinrong Li^*, Zhixiang Hu^*, Qili Shi, Wenying Qiu, Yizhe Liu, Yanfang Liu, Shenglin Huang, Linhui Liang, Zhiao Chen^#, Xianghuo He^#. Elevated choline drives KLF5-dominated transcriptional reprogramming to facilitate liver cancer progression.Oncogene. 2024. 43(42):3121-3136.  doi: 10.1038/s41388-024-03150-w.

5. Yong Wu^*, Siyu Chen^*, Yang Shao^*, Ying Su, Qin Li, Jiangchun Wu, Jun Zhu, Hao Wen, Yan Huang, Zhong Zheng, Xiaojun Chen, Xingzhu Ju, Shenglin Huang^#, Xiaohua Wu^#, Zhixiang Hu^#. KLF5 Promotes Tumor Progression and Parp Inhibitor Resistance in Ovarian Cancer.Advanced Science. 2023. 10(31):e2304638. doi: 10.1002/advs.202304638.

6. Qin Li^*, Hongyan Lai^*, Yuchen Li, Bing Chen, Siyuan Chen, Yan Li, Zhaohui Huang, Zhiqiang Meng, Peng Wang, Zhixiang Hu^#, Shenglin Huang^#. RJunBase: a database of RNA splice junctions in human normal and cancerous tissues. Nucleic Acids Resarch. 2021.  49(D1):D201-D211. doi: 10.1093/nar/gkaa1056.

7. Zhixiang Hu^*, Liangqing Dong ^*, Shengli Li, Zhe Li, Yejun Qiao, Yuchen Li, Jie Ding, Zhiao Chen, Yangjun Wu, Zhen Wang, Shenglin Huang, Qiang Gao ^#, Yingjun Zhao^#, Xianghuo He^#. Splicing Regulator p54nrb /Non-POU Domain-Containing Octamer-Binding Protein Enhances Carcinogenesis Through Oncogenic Isoform Switch of MYC Box-Dependent Interacting Protein 1 in Hepatocellular Carcinoma. Hepatology. 2020 Aug;72(2):548-568. doi: 10.1002/hep.31062.